Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

How EvoLV Stands Out Among Biotech Advisory Firms: A Comparative Analysis

Mar 05, 2025

Understanding the Biotech Advisory Landscape

The biotech industry is a rapidly evolving field, characterized by constant innovation and complex challenges. Biotech advisory firms play a crucial role in guiding companies through this dynamic landscape. They offer expertise in areas such as regulatory compliance, market strategy, and investment opportunities. With numerous firms offering similar services, it's essential to understand what makes a particular advisory firm stand out from the rest.

biotech consulting

EvoLV's Unique Approach

EvoLV stands out among biotech advisory firms due to its distinctive approach that combines in-depth industry knowledge with a commitment to personalized service. Unlike many firms that offer generalized advice, EvoLV tailors its strategies to meet the specific needs of each client. This bespoke approach ensures that companies receive the most relevant and effective guidance possible.

One of the key differentiators for EvoLV is its team of experts who have extensive experience in various sectors of the biotech industry. This diverse expertise allows EvoLV to offer a comprehensive range of services that address the multifaceted challenges faced by biotech companies today.

Comprehensive Services Offered by EvoLV

EvoLV provides a wide array of services that cater to different aspects of the biotech sector. Some of these services include:

  • Regulatory Consulting: Helping clients navigate complex regulatory environments with ease.
  • Market Analysis: Providing insights into market trends and opportunities to help companies stay competitive.
  • Investment Strategy: Guiding clients in securing funding and making informed investment decisions.
  • Strategic Partnerships: Assisting in the formation of strategic alliances to foster growth and innovation.
biotech team meeting

Client-Centric Philosophy

At the heart of EvoLV's success is its client-centric philosophy. The firm places a high value on building strong, long-term relationships with its clients. By fostering open communication and collaboration, EvoLV ensures that client goals are clearly understood and strategically pursued. This approach not only builds trust but also results in more effective solutions tailored to each client's unique challenges.

Case Studies: Success Stories

EvoLV's impact can be seen through its numerous success stories. For example, EvoLV helped a mid-sized biotech company streamline its regulatory processes, leading to faster product approvals and significant cost savings. In another instance, EvoLV's market analysis enabled a client to identify a lucrative niche market, resulting in a successful product launch and increased market share.

success story biotech

Why Choose EvoLV?

Choosing the right advisory firm is crucial for any biotech company aiming for success. EvoLV stands out not only for its expertise and comprehensive service offerings but also for its personalized approach to client engagement. By prioritizing client needs and maintaining a focus on delivering tangible results, EvoLV has established itself as a leader in the biotech advisory space.

For biotech companies looking to navigate the complexities of their industry, partnering with EvoLV offers a strategic advantage. With its proven track record, dedicated team, and client-first mentality, EvoLV is well-equipped to help companies achieve their goals and thrive in an ever-changing environment.